Dr. Kyle A. Parrow, MD

Dr. Parrow practices at Citrus Surgery Center in Lecanto, Florida.

Dr. Parrow's NPI, 1033221510, was assigned on August 31, 2006. Dr. Parrow graduated from Tufts University School Of Medicine in 1986. Dr. Parrow holds Florida license ME0060384.

Dr. Parrow's primary practice is Citrus Surgery Center, at 110 North Lecanto Highway, Lecanto, FL 34461. The practice phone is (904) 527-1825.

Dr. Parrow's primary practice is Citrus Surgery Center in Lecanto, Florida. Dmand AI also links Dr. Parrow to 1 group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parrow practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Parrow's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Parrow is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Parrow's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Parrow treats.

CMS data shows 22,156 Medicare services from Dr. Parrow across 20 procedure codes in 2024, for 2,378 Medicare patients. Medicare paid $456,542 for them.

CMS counts 2,378 Medicare patients who saw Dr. Parrow in 2024. The largest group is 75 to 84, with 1,144 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Parrow's median patient age at 79, with 56% women.

In 2024, Dr. Parrow wrote 4,864 Medicare Part D claims for 761 patients. 62% of them were for generic drugs. CMS names the drug for 4,776 of them, across 32 drugs with 11 or more claims each, at $755,004 in total drug cost. In 2023, CMS named 4,199 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Parrow for performance year 2024, reported as part of a group. Dr. Parrow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 346 procedures of cataract surgery by Dr. Parrow, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Parrow. The most frequent topics are Trabeculectomy, Glaucoma, Open-Angle and Intraocular Pressure. Dr. Parrow has published most often in Ophthalmic Surg. Dr. Parrow's most frequent co-authors are Clark S. Tsai, MD, Ronald P. Swendris, MD and John Henry Zeiter, MD.

CMS Open Payments shows 206 general payments to Dr. Parrow from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $999.

Dr. Parrow graduated from Tufts University School Of Medicine in 1986.

Dr. Parrow is in network with 7 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.